0001689748-20-000001.txt : 20200131 0001689748-20-000001.hdr.sgml : 20200131 20200131125205 ACCESSION NUMBER: 0001689748-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200131 DATE AS OF CHANGE: 20200131 EFFECTIVENESS DATE: 20200131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLARIS PHARMA CORP CENTRAL INDEX KEY: 0001689748 IRS NUMBER: 472145413 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-359482 FILM NUMBER: 20564276 BUSINESS ADDRESS: STREET 1: 1031 ROUTE 202-206, SUITE G-200 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-720-2617 MAIL ADDRESS: STREET 1: 1031 ROUTE 202-206, SUITE G-200 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 D 1 primary_doc.xml X0708 D LIVE 0001689748 SOLARIS PHARMA CORP 1031 ROUTE 202-206, SUITE G-200 BRIDGEWATER NJ NEW JERSEY 08807 908-864-0404 NEW JERSEY None None Corporation true Srinivas Lakshmi Raghavan c/o Solaris Pharma Corporation 1031 Route 202-206, Suite G-200 Bridgewater NJ NEW JERSEY 08807 Executive Officer Director Bernhard Hampl c/o Solaris Pharma Corporation 1031 Route 202-206, Suite G-200 Bridgewater NJ NEW JERSEY 08807 Director Helmut Jeggle c/o Solaris Pharma Corporation 1031 Route 202-206, Suite G-200 Bridgewater NJ NEW JERSEY 08807 Director Satish Pejaver c/o Solaris Pharma Corporation 1031 Route 202-206, Suite G-200 Bridgewater NJ NEW JERSEY 08807 Executive Officer Director Manish Potti c/o Solaris Pharma Corporation 1031 Route 202-206, Suite G-200 Bridgewater NJ NEW JERSEY 08807 Director Pharmaceuticals Decline to Disclose 06b false 2019-12-09 false true false 0 10000000 10000000 0 false 6 0 0 0 false SOLARIS PHARMA CORP /s/Satish Pejaver Satish Pejaver Chief Executive Officer 2020-01-31